Competitor Analysis: CEA Antibodies

Published by: La Merie S.L.

Published: Apr. 7, 2009 - 5 Pages

Table of Contents

• CEA Antagonists in Oncology
• Corporate CEA Antagonist R&D Pipelines
• About La Merie
  

Abstract

The present Competitive Intelligence Report about CEA Antagonists provides a competitor evaluation in the field of investigational antibodies and vaccines targeting carcinoembryonic antigen (CEA) for treatment of cancer as of April 2009.

The report includes a compilation of current active projects in research and development of epithelial cell adhesion molecule (EpCAM) targeting antibodies and antibody-based constructs. In addition, the report lists company-specific R&D pipelines of EpCAM Antagonists. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.
  

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.